Blockade of PD-1 immunosuppression boosts CAR T-cell therapy.

John, Liza B; Kershaw, Michael H; Darcy, Phillip K

John, Liza B; Kershaw, Michael H; Darcy, Phillip K.

Afiliación

John LB; Cancer Immunology Program; Peter MacCallum Cancer Centre; East Melbourne, VIC Australia ; Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville, VIC Australia.
Kershaw MH; Cancer Immunology Program; Peter MacCallum Cancer Centre; East Melbourne, VIC Australia ; Department of Pathology; University of Melbourne; Parkville, VIC Australia ; Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville, VIC Australia ; Department of Immunology; Monash University; Clayton, VIC Australia.
Darcy PK; Cancer Immunology Program; Peter MacCallum Cancer Centre; East Melbourne, VIC Australia ; Department of Pathology; University of Melbourne; Parkville, VIC Australia ; Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville, VIC Australia ; Department of Immunology; Monash University; Clayton, VIC Australia.

Oncoimmunology ; 2(10): e26286, 2013 Oct 01.

Article en En | MEDLINE | ID: mdl-24353912

Palabras clave

PD-1 blockade; adoptive immunotherapy; cancer; chimeric antigen receptor; immune response

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2013 Tipo del documento: Article